• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚合物纳米颗粒辅助化疗胰腺癌

Polymer nanoparticle-assisted chemotherapy of pancreatic cancer.

作者信息

Su Tianqi, Yang Bo, Gao Tianren, Liu Tongjun, Li Jiannan

机构信息

Department of General Surgery, The Second Hospital of Jilin University, Changchun, People's Republic of China.

Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun, People's Republic of China.

出版信息

Ther Adv Med Oncol. 2020 May 8;12:1758835920915978. doi: 10.1177/1758835920915978. eCollection 2020.

DOI:10.1177/1758835920915978
PMID:32426046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7222269/
Abstract

Pancreatic cancer is a lethal disease characterized by highly dense stroma fibrosis. Only 15-20% of patients with pancreatic cancer have resectable tumors, and only around 20% of them survive to 5 years. Traditional cancer treatments have little effect on their prognosis, and successful surgical resection combined with effective perioperative therapy is the main method for maximizing long-term survival. For this reason, chemotherapy is an adjunct treatment for resectable cancer and is the main therapy for incurable pancreatic cancer, including metastatic pancreatic adenocarcinoma. However, there are various side effects of chemotherapeutic medicine and low drug penetration because the complex tumor microenvironment limits the application of chemotherapy. As a novel strategy, polymer nanoparticles make it possible to target the tumor microenvironment, release cytotoxic agents through various responsive reactions, and thus overcome the treatment barrier. As drug carriers, polymer nanoparticles show marked advantages, such as increased drug delivery and efficiency, controlled drug release, decreased side effects, prolonged half-life, and evasion of immunogenic blockade. In this review, we discuss the factors that cause chemotherapy obstacles in pancreatic cancer, and introduce the application of polymer nanoparticles to treat pancreatic cancer.

摘要

胰腺癌是一种以高度致密的间质纤维化为特征的致命疾病。只有15%-20%的胰腺癌患者有可切除的肿瘤,其中只有约20%的患者能存活5年。传统的癌症治疗方法对其预后影响甚微,成功的手术切除联合有效的围手术期治疗是实现长期生存最大化的主要方法。因此,化疗是可切除癌症的辅助治疗方法,也是不可治愈的胰腺癌(包括转移性胰腺腺癌)的主要治疗方法。然而,由于复杂的肿瘤微环境限制了化疗的应用,化疗药物存在各种副作用且药物渗透性低。作为一种新策略,聚合物纳米颗粒能够靶向肿瘤微环境,通过各种响应反应释放细胞毒性药物,从而克服治疗障碍。作为药物载体,聚合物纳米颗粒具有显著优势,如提高药物递送和效率、控制药物释放、减少副作用、延长半衰期以及逃避免疫原性阻断。在这篇综述中,我们讨论了导致胰腺癌化疗障碍的因素,并介绍了聚合物纳米颗粒在治疗胰腺癌中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/3d055d039cc3/10.1177_1758835920915978-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/becab3eafee3/10.1177_1758835920915978-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/d79f4060cc52/10.1177_1758835920915978-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/8eb1cab360af/10.1177_1758835920915978-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/3d055d039cc3/10.1177_1758835920915978-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/becab3eafee3/10.1177_1758835920915978-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/d79f4060cc52/10.1177_1758835920915978-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/8eb1cab360af/10.1177_1758835920915978-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7fe/7222269/3d055d039cc3/10.1177_1758835920915978-fig4.jpg

相似文献

1
Polymer nanoparticle-assisted chemotherapy of pancreatic cancer.聚合物纳米颗粒辅助化疗胰腺癌
Ther Adv Med Oncol. 2020 May 8;12:1758835920915978. doi: 10.1177/1758835920915978. eCollection 2020.
2
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.癌症的先进靶向疗法:药物纳米载体,化疗的未来。
Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23.
3
Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer.纳米制剂α-山竹黄酮和雷公藤甲素的序贯递送克服了渗透障碍并提高了胰腺癌的治疗效果。
Biomaterials. 2020 May;241:119907. doi: 10.1016/j.biomaterials.2020.119907. Epub 2020 Feb 20.
4
Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.梯度肿瘤微环境促进穿透胶束缓解胰腺癌缺氧和逆转免疫抑制。
Acta Biomater. 2023 Sep 1;167:387-400. doi: 10.1016/j.actbio.2023.05.047. Epub 2023 Jun 4.
5
Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.部分配体掩蔽纳米颗粒通过肿瘤基质重编程的多功能范式改善胰腺导管腺癌的治疗。
Acta Biomater. 2022 Jun;145:122-134. doi: 10.1016/j.actbio.2022.03.050. Epub 2022 Apr 2.
6
Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.温和的发热可通过尺寸可调的纳米颗粒促进基于免疫检查点阻断的免疫疗法治疗转移性胰腺癌。
Acta Biomater. 2021 Oct 1;133:244-256. doi: 10.1016/j.actbio.2021.05.002. Epub 2021 May 14.
7
Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma.在胰腺导管腺癌裸鼠模型中评估和优化电穿孔辅助肿瘤纳米颗粒摄取
Int J Nanomedicine. 2014 Sep 1;9:4169-76. doi: 10.2147/IJN.S63324. eCollection 2014.
8
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma.原发性化疗治疗交界可切除和局部进展期胰腺导管腺癌的结果。
JAMA Surg. 2019 Oct 1;154(10):932-942. doi: 10.1001/jamasurg.2019.2277.
9
Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma.用于胰腺癌成像与治疗的纳米医学
Front Bioeng Biotechnol. 2019 Nov 13;7:307. doi: 10.3389/fbioe.2019.00307. eCollection 2019.
10
Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.胶原酶纳米颗粒增强药物渗透入胰腺肿瘤。
ACS Nano. 2019 Oct 22;13(10):11008-11021. doi: 10.1021/acsnano.9b02395. Epub 2019 Sep 20.

引用本文的文献

1
Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC.针对胰腺癌肿瘤微环境的纳米医学策略的广泛综述
Int J Nanomedicine. 2025 Mar 17;20:3379-3406. doi: 10.2147/IJN.S504503. eCollection 2025.
2
Advances and prospects of precision nanomedicine in personalized tumor theranostics.精准纳米医学在个性化肿瘤诊疗中的进展与展望
Front Cell Dev Biol. 2024 Dec 5;12:1514399. doi: 10.3389/fcell.2024.1514399. eCollection 2024.
3
Impact of stroma remodeling on forces experienced by cancer cells and stromal cells within a pancreatic tumor tissue.

本文引用的文献

1
Extramammary Paget Disease: A Review of the Literature-Part I: History, Epidemiology, Pathogenesis, Presentation, Histopathology, and Diagnostic Work-up.乳房外帕哲病:文献回顾——第一部分:历史、流行病学、发病机制、临床表现、组织病理学和诊断方法。
Dermatol Surg. 2020 Feb;46(2):151-158. doi: 10.1097/DSS.0000000000002064.
2
Antitumor Activity of 1,18-Octadecanedioic Acid-Paclitaxel Complexed with Human Serum Albumin.1,18-十八烷二酸-紫杉醇与人血清白蛋白复合物的抗肿瘤活性。
J Am Chem Soc. 2019 Jul 31;141(30):11765-11769. doi: 10.1021/jacs.9b04272. Epub 2019 Jul 18.
3
Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
基质重构对胰腺肿瘤组织中癌细胞和基质细胞所受压力的影响。
Biomed Eng Online. 2024 Aug 30;23(1):88. doi: 10.1186/s12938-024-01278-0.
4
Modeling Physical Forces Experienced by Cancer and Stromal Cells Within Different Organ-Specific Tumor Tissue.模拟不同器官特异性肿瘤组织中癌细胞和基质细胞所经历的物理力。
IEEE J Transl Eng Health Med. 2024 Apr 15;12:413-434. doi: 10.1109/JTEHM.2024.3388561. eCollection 2024.
5
Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing.基于 ac4C 修饰基因的胰腺癌分型中的免疫反应和药物治疗。
Front Immunol. 2023 Mar 6;14:1133166. doi: 10.3389/fimmu.2023.1133166. eCollection 2023.
6
Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies.海洋启发药物和生物材料在胰腺癌治疗中的应用
Mar Drugs. 2022 Nov 1;20(11):689. doi: 10.3390/md20110689.
7
Evaluation of 20(S)-ginsenoside Rg3 loaded hydrogel for the treatment of perianal ulcer in a rat model.评价负载20(S)-人参皂苷Rg3的水凝胶对大鼠肛周溃疡的治疗作用
J Ginseng Res. 2022 Nov;46(6):771-779. doi: 10.1016/j.jgr.2022.03.002. Epub 2022 Mar 11.
8
A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.基于线粒体自噬相关基因构建的signature 预测乳腺癌的预后和治疗反应。
Aging (Albany NY). 2022 Aug 5;14(15):6169-6186. doi: 10.18632/aging.204209.
9
Tumor Cell-Specific and Lipase-Responsive Delivery of Hydrogen Sulfide for Sensitizing Chemotherapy of Pancreatic Cancer.用于胰腺癌化疗增敏的肿瘤细胞特异性及脂肪酶响应性硫化氢递送
Front Bioeng Biotechnol. 2022 Jul 11;10:934151. doi: 10.3389/fbioe.2022.934151. eCollection 2022.
10
Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment.基于m6A相关lncRNA的胰腺癌模型特征及其肿瘤微环境的深度生物信息学分析预测的药物靶点的预后价值
Front Genet. 2022 Apr 25;13:853471. doi: 10.3389/fgene.2022.853471. eCollection 2022.
人胰腺星状细胞分泌的纤连蛋白促进胰腺癌细胞对吉西他滨的化疗耐药性。
BMC Cancer. 2019 Jun 17;19(1):596. doi: 10.1186/s12885-019-5803-1.
4
Influence of the PLGA/gelatin ratio on the physical, chemical and biological properties of electrospun scaffolds for wound dressings.用于伤口敷料的电纺支架的 PLGA/明胶比例对其物理、化学和生物学性能的影响。
Biomed Mater. 2019 May 3;14(4):045006. doi: 10.1088/1748-605X/ab1741.
5
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma.缺氧作为胰腺腺癌免疫治疗的障碍。
Clin Transl Med. 2019 Apr 1;8(1):10. doi: 10.1186/s40169-019-0226-9.
6
TAMing pancreatic cancer: combat with a double edged sword.TAM 抑制胰腺癌:双刃剑的战斗。
Mol Cancer. 2019 Mar 30;18(1):48. doi: 10.1186/s12943-019-0966-6.
7
Role of the tumor microenvironment in pancreatic cancer.肿瘤微环境在胰腺癌中的作用。
Ann Gastroenterol Surg. 2019 Jan 4;3(2):130-137. doi: 10.1002/ags3.12225. eCollection 2019 Mar.
8
Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.用于药物研发的胰腺癌三维共培养球体模型的建立与分析
Methods Mol Biol. 2019;1953:163-179. doi: 10.1007/978-1-4939-9145-7_11.
9
Enhanced anti-proliferative and pro-apoptotic effects of metformin encapsulated PLGA-PEG nanoparticles on SKOV3 human ovarian carcinoma cells.载二甲双胍 PLGA-PEG 纳米粒增强对 SKOV3 人卵巢癌细胞的抗增殖和促凋亡作用。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):737-746. doi: 10.1080/21691401.2019.1573737.
10
Synergistic Action of Gefitinib and GSK41364A Simultaneously Loaded in Ratiometrically-Engineered Polymeric Nanoparticles for Glioblastoma Multiforme.吉非替尼和GSK41364A同时负载于比例工程化聚合物纳米颗粒中对多形性胶质母细胞瘤的协同作用
J Clin Med. 2019 Mar 15;8(3):367. doi: 10.3390/jcm8030367.